Selection and Use of Umbilical Cord Cell Fractions Suitable for Transplantation (2019)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,746,325 | Selection and Use of Umbilical Cord Cell Fractions Suitable for Transplantation In force · High confidence | Gamida Cell Ltd. | In force | High confidence | ||
| Application 18/343,187 | Selection and Use of Umbilical Cord Cell Fractions Suitable for Transplantation Abandoned Abandoned Aug 22, 2025 | Gamida Cell Ltd. | Abandoned | Abandoned Aug 22, 2025 | not computed | |
| Application 18/775,649 | Selection and Use of Umbilical Cord Cell Fractions Suitable for Transplantation Pending Not granted | Gamida Cell Ltd. | Pending | Not granted | not computed |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Gamida Cell Ltd..
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.